Abstract.
Despite experimental evidence that sulforaphane can exert chemopreventive effects, whether these effects are specific for neoplastic cells is not known. Following our previous demonstration that sulforaphane induces cell cycle arrest and apoptosis in human T lymphoblastoid Jurkat leukemia cells and increases p53 and bax protein expression, we tested sulforaphane on non-transformed phytohemagglutinin-stimulated human lymphocytes. Here, we demonstrate that sulforaphane arrested cell cycle progression in G1 phase, through a decrease in the protein expression of cyclin D3. Moreover, sulforaphane induced apoptosis (and also necrosis), mediated by an increase in the expression of p53. These findings suggest that sulforaphane is a growth modulator for T cells. Our in vitro evidence that sulforaphane is active and even cytotoxic in normal as well as transformed lymphocytes raises important questions regarding its suitability for cancer chemoprevention.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received 26 July 2002; received after revision 2 September 2002; accepted 10 September 2002
RID="*"
ID="*"Corresponding author.
Rights and permissions
About this article
Cite this article
Fimognari, C., Nüsse, M., Berti, F. et al. Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T lymphocytes. CMLS, Cell. Mol. Life Sci. 59, 2004–2012 (2002). https://doi.org/10.1007/PL00012523
Issue Date:
DOI: https://doi.org/10.1007/PL00012523